Mitsui Kinzoku Co Valuation Multiples

Mitsui Kinzoku Co is valued at $8.5B as of October 2026, a 1.7x revenue multiple. In the last 12 months, Mitsui Kinzoku Co revenue was $5.1B and Mitsui Kinzoku Co EBITDA was $946M.

Mitsui Kinzoku Co Overview

About Mitsui Kinzoku Co

Mitsui Kinzoku Co Ltd is a Japanese company. The company is engaged in the manufacturing and sales of functional materials and electronic materials, non-ferrous metal smelting, resource development, precious metal recycling, materials-related businesses, manufacturing and sales of automotive parts, and others. The company operates in segments, namely, Engineered Materials, Metals, Business creation, Business evaluation, and other businesses.


Founded

1950

HQ

Japan

Employees

12.1K

Financials (LTM)

Revenue: $5.1B
EBITDA: $946M

EV

$8.9B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mitsui Kinzoku Co Financials

Mitsui Kinzoku Co reported last 12-month revenue of $5.1B and EBITDA of $946M.

In the same LTM period, Mitsui Kinzoku Co generated $1.2B in gross profit, $946M in EBITDA, and $562M in net income.


Mitsui Kinzoku Co P&L

In the most recent fiscal year, Mitsui Kinzoku Co reported revenue of $4.8B and EBITDA of $940M.

Mitsui Kinzoku Co is profitable as of last fiscal year, with gross margin of 27%, EBITDA margin of 20%, and net margin of 12%.

See analyst estimates for Mitsui Kinzoku Co
LTMLast FY202620272028
Revenue$5.1B$4.8B
Gross Profit$1.2B$1.3B
Gross Margin24%27%
EBITDA$946M$940M
EBITDA Margin18%20%
EBIT Margin15%17%
Net Profit$562M$577M
Net Margin11%12%
Net Debt-$356M

Financial data powered by Morningstar, Inc.

Mitsui Kinzoku Co Stock Performance

Mitsui Kinzoku Co has current market cap of $8.5B, and enterprise value of $8.9B.

Market Cap Evolution


Mitsui Kinzoku Co's stock price is $14.80.

Mitsui Kinzoku Co has an EPS (earnings per share) of $1.01.

See more trading valuation data for Mitsui Kinzoku Co
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8.9B$8.5B0.0%---$1.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mitsui Kinzoku Co Valuation Multiples

Mitsui Kinzoku Co trades at 1.7x EV/Revenue multiple, and 9.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Mitsui Kinzoku Co

Mitsui Kinzoku Co Financial Valuation Multiples

As of October 18, 2026, Mitsui Kinzoku Co has market cap of $8.5B and EV of $8.9B.

Mitsui Kinzoku Co has a P/E ratio of 15.1x.

LTMLast FY202620272028
EV/Revenue1.7x1.9x
EV/EBITDA9.5x9.5x
EV/EBIT11.9x10.8x
EV/Gross Profit7.4x7.0x
P/E15.1x14.7x
EV/FCF34.5x27.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mitsui Kinzoku Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mitsui Kinzoku Co Margins & Growth Rates

Mitsui Kinzoku Co grew revenue by 13% but EBITDA decreased by 3% in the last fiscal year.

In the most recent fiscal year, Mitsui Kinzoku Co reported gross margin of 27%, EBITDA margin of 20%, and net margin of 12%.

See estimated margins and future growth rates for Mitsui Kinzoku Co

Mitsui Kinzoku Co Margins

Last FY2026202720282029
Gross Margin27%22%
EBITDA Margin20%18%
EBIT Margin17%14%
Net Margin12%11%
FCF Margin7%4%

Mitsui Kinzoku Co Growth Rates

FY+1/FY26/2727/2828/29
Revenue Growth13%
Gross Profit Growth(11%)
EBITDA Growth(3%)
EBIT Growth(16%)
Net Profit Growth(5%)
FCF Growth(55%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Mitsui Kinzoku Co Operational KPIs

Mitsui Kinzoku Co's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Mitsui Kinzoku Co
LTMLast FY202620272028
Rule of 4026%-
Bessemer Rule of X38%-
Revenue per Employee-$0.4M
Opex per Employee-$0.0M
R&D Expenses to Revenue2%2%
Opex to Revenue-9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mitsui Kinzoku Co Competitors

Mitsui Kinzoku Co competitors include Zhaojin Mining Industry, Xiamen Tungsten, Metlen Energy & Metals, Sociedad Química y Minera, First Majestic Silver, DPM Metals, Zhejiang Huayou Cobalt, Minas Buenaventura, Lynas Rare Earths and China Steel.

Most Mitsui Kinzoku Co public comparables operate across Metals & Mining.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Zhaojin Mining Industry$2.7B$1.1B3.6x3.8x8.6x9.3x
Xiamen Tungsten$6.9B$852M1.7x1.1x13.9x11.6x
Metlen Energy & Metals$8B$798M1.4x1.3x14.0x9.5x
Sociedad Química y Minera$4.6B$1.5B2.6x1.6x8.2x3.4x
First Majestic Silver$1.3B$660M5.8x4.7x11.1x7.7x
DPM Metals$950M$504M8.8x6.4x16.6x9.6x
Zhejiang Huayou Cobalt$12B$2.3B1.5x1.2x7.9x7.2x
Minas Buenaventura$1.7B$1.1B4.6x3.6x7.2x6.8x

This data is available for Pro users. Sign up to see all Mitsui Kinzoku Co competitors and their valuation data.

Start Free Trial

Investments by Mitsui Kinzoku Co

Mitsui Kinzoku Co has invested in 5 companies to date.

Latest investment by Mitsui Kinzoku Co was on October 9th 2026. Mitsui Kinzoku Co invested in RadioNano Therapeutics in their Series B round.

See VC round multiples

Latest Investments by Mitsui Kinzoku Co

RadioNano Therapeutics
WaHa
Chitose Group
Alpha Fusion
Description
RadioNano Therapeutics is an Oslo-based developer of boronated compounds for Boron Neutron Capture Therapy targeting glioblastoma and melanoma. Its lead candidate, RNT-1, delivers 10B isotopes selectively to cancer cells, enabling neutron irradiation at facilities like MIT reactor. The company advances phase I trials in Scandinavia with support from Nordic Neutron Science programs. Established in 2017, RadioNano collaborates with Oslo University Hospital for preclinical validation.
WaHa is a Berkeley-based developer of the WaHa Vaporator solid desiccant regeneration engine for air conditioning. The patented system reduces energy use by up to 90 percent for cooling, dehumidification, and water generation, founded in 2018 to commercialize UC Berkeley technologies via wahainc.com.
Chitose Group is a biotechnology conglomerate with operations in Singapore, Japan, and Indonesia focused on microalgae cultivation for sustainable products. It engineers strains for DHA omega-3 oils used in infant formula by Nestle and DSM, biofuel feedstocks, and animal feed additives replacing fishmeal. The group operates 50-hectare photobioreactor farms producing 10,000 tons annually, advancing carbon capture in aquaculture and cosmetics.
Alpha Fusion is a developer of radiopharmaceuticals using astatine-211 for targeted alpha therapy in cancer treatment. Copenhagen-based, it produces At-211 labeled antibodies for clinical trials in prostate and neuroendocrine tumors. Founded in 2021, the company collaborates with Rigshospitalet and holds patents for chelator technology enabling 10-hour half-life delivery, positioning it as a leader in next-gen radio-oncology.
HQ CountryJapanUnited StatesJapanJapan
HQ City
Kyoto
San Francisco, CA
Kawasaki
Osaka
Deal Date9 Oct 202610 Jul 202510 Mar 20258 Oct 2024
RoundSeries BSeries AUndisclosed stageSeries B
Raisedundisclosed$8M$28M$7M
InvestorsMitsui Kinzoku Co; Kyoto University Innovation CapitalAnthropocene Institute; Mitsui Kinzoku Co; Vesta Fund; Christian Thirion; Mike Phillips; Berkeley Catalyst Fund (BCF)NGK Insulators; Amano Enzyme; Mizuho Financial Group; Mers Line; JAFCO Asia; NSK; Mitsui Kinzoku Co; Shinsho; Mitsubishi Kakoki Kaisha; Shiseido; Ikeda Saccharification Industry; Sumitomo Mitsui Trust BankJGC Holdings; SBI Investment; Mitsui Kinzoku Co; Joyo Capital Partners; D3; Kobe University Capital; Osaka University Venture Capital
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Mitsui Kinzoku Co investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mitsui Kinzoku Co

When was Mitsui Kinzoku Co founded?Mitsui Kinzoku Co was founded in 1950.
Where is Mitsui Kinzoku Co headquartered?Mitsui Kinzoku Co is headquartered in Japan.
How many employees does Mitsui Kinzoku Co have?As of today, Mitsui Kinzoku Co has over 12K employees.
Is Mitsui Kinzoku Co publicly listed?Yes, Mitsui Kinzoku Co is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Mitsui Kinzoku Co?Mitsui Kinzoku Co trades under 5706 ticker.
When did Mitsui Kinzoku Co go public?Mitsui Kinzoku Co went public in 1950.
Who are competitors of Mitsui Kinzoku Co?Mitsui Kinzoku Co main competitors include Zhaojin Mining Industry, Xiamen Tungsten, Metlen Energy & Metals, Sociedad Química y Minera, First Majestic Silver, DPM Metals, Zhejiang Huayou Cobalt, Minas Buenaventura, Lynas Rare Earths, China Steel.
What is the current market cap of Mitsui Kinzoku Co?Mitsui Kinzoku Co's current market cap is $8.5B.
What is the current revenue of Mitsui Kinzoku Co?Mitsui Kinzoku Co's last 12 months revenue is $5.1B.
What is the current revenue growth of Mitsui Kinzoku Co?Mitsui Kinzoku Co revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Mitsui Kinzoku Co?Current revenue multiple of Mitsui Kinzoku Co is 1.7x.
What is the current EBITDA of Mitsui Kinzoku Co?Mitsui Kinzoku Co's last 12 months EBITDA is $946M.
What is Mitsui Kinzoku Co's EBITDA margin?Mitsui Kinzoku Co's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Mitsui Kinzoku Co?Current EBITDA multiple of Mitsui Kinzoku Co is 9.5x.
What is the current FCF of Mitsui Kinzoku Co?Mitsui Kinzoku Co's last 12 months FCF is $259M.
What is Mitsui Kinzoku Co's FCF margin?Mitsui Kinzoku Co's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Mitsui Kinzoku Co?Current FCF multiple of Mitsui Kinzoku Co is 34.5x.
How many companies Mitsui Kinzoku Co has acquired to date?Mitsui Kinzoku Co hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mitsui Kinzoku Co has invested to date?As of October 2026, Mitsui Kinzoku Co has invested in 5 companies.
What was the last Mitsui Kinzoku Co investment?On 9th October 2026 Mitsui Kinzoku Co invested in RadioNano Therapeutics, participating in a Series B round, alongside Kyoto University Innovation Capital.
In what companies Mitsui Kinzoku Co invested in?Mitsui Kinzoku Co invested in Chitose Group, WaHa, Alpha Fusion, Atomis, and RadioNano Therapeutics.

See public comps similar to Mitsui Kinzoku Co

Lists including Mitsui Kinzoku Co

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial